Utility of a single mid-trimester measurement of plasminogen activator Type 1 and fibronectin to predict preeclampsia in pregnancy.
Date
2016-08
Authors
Ajibola, S.O.
Adeyemo, T.A.
Afolabi, B.B.
Akanmu, A.S.
Journal Title
Journal ISSN
Volume Title
Publisher
Niger Med J.
Abstract
Preeclampsia (PE) is the second most common cause of maternal death after obstetric hemorrhage in Africa, a resource-limited region. This study was designed to examine the potential usefulness of a single screening plasma plasminogen activator inhibitor-1 (PAI-1) and fibronectin (FN) level for the prediction of PE in pregnant women.
Description
Keywords
Fibronectin , Plasminogen , Activator inhibitor-1 , Preeclampsia
Citation
Ajibola SO, Adeyemo TA, Afolabi BB, Akanmu AS. Utility of a single mid-trimester measurement of plasminogen activator Type 1 and fibronectin to predict preeclampsia in pregnancy. Niger Med J. 2016 Jul-Aug;57(4):213-6. doi: 10.4103/0300-1652.188337. PubMed PMID: 27630384; PubMed Central PMCID: PMC4995812.